AbCellera Biologics Inc. ABCL
Super Investor & Insider
| Data filing | Data op. | Insider | Ruolo | Tipo | Prezzo | Quantità | Valore |
|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-02-27 | Thermopylae Holdings Ltd. | 10% | Acquisto | $3.44 | +38,000 | $130,720 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
AbCellera Biologics Inc. is a biotechnology company based in Vancouver, Canada, focused on discovering and developing therapeutic antibodies. The company operates a technology-driven antibody discovery platform that integrates biology, computation, and engineering to identify drug candidates from natural immune respons…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryCanada
Employees596
TickerABCL
Statistics
Market Cap$1.70B
Revenue (TTM)$75.1M
Net Income-$146.4M
Net Margin-194.9%
EPS$-0.49
P/E-10.68
P/S20.32
P/B1.71
EV/EBITDA-6.29
ROE-14.7%
Dividend Yield—
Price$5.59
Data: Twelve Data · Revenue = mcap / P/S